DK0383234T3 - Pasteuriseret, renset von Willebrand-faktor-koncentrat og fremgangsmåde til dets fremstilling - Google Patents

Pasteuriseret, renset von Willebrand-faktor-koncentrat og fremgangsmåde til dets fremstilling

Info

Publication number
DK0383234T3
DK0383234T3 DK90102716.9T DK90102716T DK0383234T3 DK 0383234 T3 DK0383234 T3 DK 0383234T3 DK 90102716 T DK90102716 T DK 90102716T DK 0383234 T3 DK0383234 T3 DK 0383234T3
Authority
DK
Denmark
Prior art keywords
von willebrand
preparation
willebrand factor
pasteurized
factor concentrate
Prior art date
Application number
DK90102716.9T
Other languages
English (en)
Inventor
Gerhard Kumpe
Norbert Prof Dr Heimburger
Klaus Wellner
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6374025&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0383234(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Application granted granted Critical
Publication of DK0383234T3 publication Critical patent/DK0383234T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
DK90102716.9T 1989-02-14 1990-02-12 Pasteuriseret, renset von Willebrand-faktor-koncentrat og fremgangsmåde til dets fremstilling DK0383234T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3904354A DE3904354A1 (de) 1989-02-14 1989-02-14 Pasteurisiertes, gereinigtes von willebrand-faktor-konzentrat und verfahren zu seiner herstellung

Publications (1)

Publication Number Publication Date
DK0383234T3 true DK0383234T3 (da) 1995-05-01

Family

ID=6374025

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90102716.9T DK0383234T3 (da) 1989-02-14 1990-02-12 Pasteuriseret, renset von Willebrand-faktor-koncentrat og fremgangsmåde til dets fremstilling

Country Status (12)

Country Link
US (1) US6239261B1 (da)
EP (1) EP0383234B1 (da)
JP (1) JP2930243B2 (da)
KR (1) KR0149999B1 (da)
AT (1) ATE114669T1 (da)
AU (1) AU638969B2 (da)
CA (1) CA2009946C (da)
DE (2) DE3904354A1 (da)
DK (1) DK0383234T3 (da)
ES (1) ES2066020T3 (da)
IE (1) IE900511L (da)
PT (1) PT93128B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
FR2644064B1 (fr) * 1989-02-17 1994-05-27 Aquitaine Dev Transf Sanguine Procede de fabrication du facteur antihemophilique fviiic ayant une tres haute purete et facteur antihemophilique fviiic ainsi obtenu, ainsi que composition pharmaceutique le contenant
DE4435485C1 (de) * 1994-10-04 1996-03-21 Immuno Ag Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor
DE4435392B4 (de) * 1994-10-04 2008-02-07 Immuno Ag Verfahren zur Trennung von vWF in hochmolekularen vWF und niedermolekularen vWF
AT406867B (de) 1997-02-27 2000-10-25 Immuno Ag Verfahren zur gewinnung von hochreinem vwf oder faktor viii/vwf-komplex
AT405403B (de) 1997-02-27 1999-08-25 Immuno Ag Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie
US6605222B1 (en) * 1998-05-20 2003-08-12 Baxter Aktiengesellschaft Method for producing a factor VIII/von Willebrand factor complex
EP1154796B1 (en) 1999-02-22 2007-06-20 University of Connecticut Novel albumin-free factor viii formulations
DE10022092A1 (de) * 2000-05-08 2001-11-15 Aventis Behring Gmbh Stabilisiertes Protein-Präparat und Verfahren zu seiner Herstellung
US7365173B2 (en) * 2002-02-04 2008-04-29 American National Red Cross Method for the production of pure virally inactivated butyrylcholinesterase
DE10246125A1 (de) * 2002-10-01 2004-04-15 Aventis Behring Gmbh Konzentrat eines Faktor VIII:C-haltigen von-Willebrand-Faktors und das dazu gehörige Verfahren
DE102004009400A1 (de) 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung
EP1720519A1 (en) * 2004-03-04 2006-11-15 Wyeth Lyophilization method to improve excipient crystallization
FR2874216B1 (fr) 2004-08-16 2006-11-03 Lab Francais Du Fractionnement Procede de preparation d'un concentre de facteur von willebrand (fvw) par voie chromatographique et concentre de fvw susceptible d'etre ainsi obtenu
WO2006029258A2 (en) * 2004-09-07 2006-03-16 Archemix Corp. Aptamer medicinal chemistry
JP2008512098A (ja) 2004-09-07 2008-04-24 アーケミックス コーポレイション フォン・ビルブラント因子に対するアプタマー、および血栓性疾患の処置剤としてのその使用
US7566701B2 (en) * 2004-09-07 2009-07-28 Archemix Corp. Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
WO2008150495A2 (en) * 2007-06-01 2008-12-11 Archemix Corp. Vwf aptamer formulations and methods for use
BRPI0921429B1 (pt) 2008-11-07 2022-07-12 Takeda Pharmaceutical Company Limited Formulação farmacêutica liofilizada estável, e, método para preparar um fator liofilizado estável
JP6583766B2 (ja) * 2015-02-02 2019-10-02 学校法人北里研究所 タンパク質分離方法、タンパク質分析方法、及びタンパク質分離キット
KR101841587B1 (ko) 2016-01-12 2018-05-14 주식회사 녹십자홀딩스 피브리노겐의 정제방법
CN105622746A (zh) * 2016-02-04 2016-06-01 江西博雅生物制药股份有限公司 一种从冷沉淀提取凝血因子ⅷ的废料中提取人血管性血友病因子的制备工艺
CN105622747A (zh) * 2016-02-04 2016-06-01 江西博雅生物制药股份有限公司 一种vWF活性保护液
CN105541997A (zh) * 2016-02-04 2016-05-04 江西博雅生物制药股份有限公司 一种高纯度和高活性血管性血友病因子的制备工艺

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4027013A (en) * 1976-01-22 1977-05-31 William L. Wilson Clottable fibrinogen free factor VIII and albumin product and process
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
US4278594A (en) 1979-06-19 1981-07-14 David Amrani Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
US4210580A (en) 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma
GB2079292A (en) 1980-07-05 1982-01-20 Speywood Lab Ltd Blood Clotting Factor Production
US4361509A (en) 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
DE3237512A1 (de) * 1982-10-09 1984-04-12 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von antihaemophilem kryopraezipitat (ahk) und danach hergestelltes antihaemophiles kryopraezipitat
GB8403473D0 (en) 1984-02-09 1984-03-14 Special Trustees For St Thomas Purification of factor viii
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
DE3707213A1 (de) * 1987-03-06 1988-09-15 Behringwerke Ag Verfahren zur herstellung von faktor viii:c-mangelplasma und ein so erhaltenes mangelplasma
US4774323A (en) * 1987-06-29 1988-09-27 Rorer Pharmaceutical Corporation Purification of von Willebrand Factor solutions using gel permeation chromatography
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
FR2651437A1 (fr) * 1989-09-05 1991-03-08 Lille Transfusion Sanguine Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.

Also Published As

Publication number Publication date
KR0149999B1 (ko) 1998-08-17
US6239261B1 (en) 2001-05-29
KR900012615A (ko) 1990-09-01
AU4933990A (en) 1990-08-30
ES2066020T3 (es) 1995-03-01
DE3904354A1 (de) 1990-08-16
EP0383234B1 (de) 1994-11-30
PT93128A (pt) 1990-08-31
IE900511L (en) 1990-08-14
DE59007785D1 (de) 1995-01-12
CA2009946C (en) 2000-04-11
EP0383234A2 (de) 1990-08-22
ATE114669T1 (de) 1994-12-15
EP0383234A3 (de) 1991-08-07
JP2930243B2 (ja) 1999-08-03
JPH02264799A (ja) 1990-10-29
CA2009946A1 (en) 1990-08-14
PT93128B (pt) 1995-12-29
AU638969B2 (en) 1993-07-15

Similar Documents

Publication Publication Date Title
DK0383234T3 (da) Pasteuriseret, renset von Willebrand-faktor-koncentrat og fremgangsmåde til dets fremstilling
PT92278A (pt) Processo para a preparacao de proteinas de ligacao de factor de crescimento semelhante a insulina
DE3380764D1 (en) Pasteurized human fibrinogen, method of preparing it and its use
DE3677520D1 (de) Vorrichtung zur behandlung von behaeltern.
DK398185D0 (da) Pasteuriseret, hoejrenset faktor viii-praeparat og fremgangsmaade til fremstilling deraf
ATE88718T1 (de) Verfahren zur reinigung des hepatitis-oberflaechen-antigens und das so erhaltene produkt.
PT77464A (de) Verfahren zur pasteurisierung von antihaemophilem kryopraezipitat (ahk) und danach hergestelltes antihaemophiles kryopraezipittat
ZA932843B (en) A method of producing a factor VIII preparation
DE3578266D1 (de) Verfahren zum herstellen von halbleiteranordnungen und dadurch hergestellte anordnungen.
PT79117A (de) Verfahren zur pasteurisierung von humanplasma
DE3853224D1 (de) Produktion von Proteinen in aktiver Form.
EP0571771A3 (en) Method of inactivation of viruses in proteinic preparations
DE3674074D1 (de) Verfahren zur festigkeitsverbesserung durch waermebehandlung.
DE3686909D1 (de) Lymphotoxin-dns, lymphotoxin-expressionsvektor, lymphotoxin-expressionsvektor enthaltender transformant und verfahren zur herstellung von lymphotoxin.
HUT36783A (en) Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane
DE3774931D1 (de) Einrichtung zur gesteuerten waermebehandlung von weichenteilen.
DE3586197D1 (de) Verfahren zur reinigung sowie pasteurisierung von urokinase.
EP0238765A3 (en) 2,2-diphenoxy-n,n-dimethylaminoethane for improving cerebral oxygenation